Drug makers step up guard against crisis

Local drug manufacturers are placing priority on enhancing their financial structures and business portfolios to compete against much bigger foreign drug makers abroad by focusing on competitive new businesses like biomedicine.

Korean drug companies are trying to survive the government’s price cuts by slashing production costs and collaborating with foreign companies to sell products. But th...